Abstract
C-AMOX, a new prolonged acting preparation of amoxicillin was administered to122cases by oral administration of daily dosage500mg twice.
Clinical effectiveness of C-AMOX was evaluated in115out of122cases (acute simple cystitis87 cases, acute pyelonephritis6cases, complicated urinary tract infection19cases and others3cases), and the following results were obtained.
1.The clinical effect for87cases of acute simple cystitis was excellent in54cases(62%), moderate in24cases(27.6%)and poor9cases(10.3%),overall effective rate being89.7%.
2.The clinical effect for19cases of complicated urinary tract infection was excellent in6cases (31.6%),good8cases(42.1%)and poor5cases(26.3%),overall effective rate being73.7%.
3.Adverse reaction occured in2patients, one gastric discomfort and the other one slight diarrhoea. No laboratory abnormalities attributable to C-AMOX were observed in the present study.
